Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients.

JCI Insight · 2022 · PMC9090237 · PMID 35349490

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

Complete serological nonresponders, defined as IgG < 3.5 BAU/mL before fourth vaccination ( n = 15), showed a trend toward lower titers at day 32 compared with partial nonresponders with IgG > 3.5 BAU/mL before fourth vaccination ( Supplemental Figure 1D ), but this difference did not reach statistical significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.